The global distraction osteogenesis market reached US$ 238.03 million in 2023 and is expected to reach US$ 352.81 million by 2031, growing at a CAGR of 5.0% during the forecast period 2024-2031. Distraction osteogenesis is a procedure which involves controlled elongation of the bone. It is majorly used in orthopedic and craniomaxillofacial surgeries to reconstruct or lengthen the bone. The usual process involves making a controlled fracture (osteotomy) in the bone and distracting the bone fragments using a device called a distractor allowing osteogenesis. Distraction osteogenesis is an alternative technique to bone grafting and tissue transfer, which does not require bone from other parts of the body. This is commonly employed in children with bone deformities, limb length problems, or craniofacial problems.